Drug Type Chemical drugs |
Synonyms- |
Target |
Mechanism CB1 antagonists(Cannabinoid CB1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autism Spectrum Disorder | Preclinical | FR | 07 May 2024 |